Also, we did not evaluate whether ANXA1 is effective against acute and chronic itching with other etiologies, such as opioid-induced acute itching, cancer-induced chronic itching and renal failure-induced chronic itching, which is important for translating these findings to clinical patients. Here, ANXA1 is linked to acute kidney injury.